Isolated liver perfusion for hepatic tumors
著者
書誌事項
Isolated liver perfusion for hepatic tumors
(Recent results in cancer research, 147)
Springer, 1998
大学図書館所蔵 全5件
  青森
  岩手
  宮城
  秋田
  山形
  福島
  茨城
  栃木
  群馬
  埼玉
  千葉
  東京
  神奈川
  新潟
  富山
  石川
  福井
  山梨
  長野
  岐阜
  静岡
  愛知
  三重
  滋賀
  京都
  大阪
  兵庫
  奈良
  和歌山
  鳥取
  島根
  岡山
  広島
  山口
  徳島
  香川
  愛媛
  高知
  福岡
  佐賀
  長崎
  熊本
  大分
  宮崎
  鹿児島
  沖縄
  韓国
  中国
  タイ
  イギリス
  ドイツ
  スイス
  フランス
  ベルギー
  オランダ
  スウェーデン
  ノルウェー
  アメリカ
注記
Includes bibliographical references and index
内容説明・目次
内容説明
The contributions in this book were originally presented at the workshop "Research and Clinical Application of Isolated Liver Perfusion for Hepatic Tumors" held on 28 February to 1 March 1997 in Hanover, Germany. The workshop was planned to bring together groups working with isolated liver perfusion techniques worldwide. Experts from various countries were invited to pre- sent and discuss their experimental data and clinical results. USA par- Groups from Japan, The Netherlands, Sweden and the ticipated. At the beginning, oncologists, surgeons and patholo- gists presented possible indications and the oncological back- ground for therapeutic isolated liver perfusion from their points of view. Based on data from previous studies about loco regional chemotherapy and based on the pathology of metastasis, it could be concluded that there is a place for isolated liver perfusion in the therapy of liver cancer. Second, different surgical techniques of isolated liver perfusion were presented. These techniques var- ied from a percutaneous approach with extracorporeal chemofil- tration to extended open abdominal surgery.
Perfusion of the liv- er without a considerable amount of drug reaching the systemic circulation proved to be possible. The complex procedure with complicated extracorporeal perfusion technique represented a disadvantage of the methods presented. Further studies should simplify the technical and surgical aspects. Intraoperative and postoperative management of . patients undergoing isolated liver perfusion were also discussed. Coagulopathy was one important aspect which can occur during isolated liver perfusion. The per- centage of leakage determined systemic side effects.
目次
Indication.- Are There Indications for Intraarterial Hepatic Chemotherapy or Isolated Liver Perfusion? The Case of Liver Metastases from Colorectal Cancer. Indications for Isolated Hyperthermic Liver Perfusion: A Surgeon's View. Techniques/Anaesthesia.- Asanguineous Isolated Hyperthermic Perfusion of the Liver: Results of an Experimental Study in Pigs. Hyperthermo-Chemo-Hypoxic Isolated Liver Perfusion for Hepatic Metastases: A Possible Adjuvant Approach. The Surgical Technique of Isolated Hyperthermic Arterial Liver Perfusion in Humans. Monitoring Leakage During Isolated Hepatic Perfusion. Anesthesiological Management During Isolated Liver Perfusion. High-Dose Chemoperfusion.- Percutaneous Isolated Liver Chemoperfusion for Treatment of Unresectable Malignant Liver Tumors: Technique, Pharmacokinetics, Clinical Results. Phase I/II Studies of Isolated Hepatic Perfusion with Mitomycin C or Melphalan in Patients with Colorectal Cancer. Tumor Necrosis Factor.- Molecular Mechanisms of TNF Receptor-Mediated Signaling. Isolated Hepatic Perfusion with Tumor Necrosis Factor Alpha and Melphalan: Experimental Studies in Pigs and Phase I Data from Humans. Isolated Hepatic Perfusion with Extracorporeal Oxygenation Using Hyperthermia, TNF Alpha and Melphalan: Swedish Experience. Radiological Control of Tumor Response.- Role of Ultrasonography for Monitoring Tumor Necrosis After Chemotherapy. CT and MR to Assess the Response of Liver Tumors to Hepatic Perfusion. Future Aspects.- Implications of Shock Proteins Druing Liver Surgery and Liver Perfusion. Towards Gene Therapy for Colorectal Liver Metastases. Subject Index.-
「Nielsen BookData」 より